Wearable biosensors, biomarker detection, medical devices and microelectronics, point-of-care testing, molecular diagnostics, biomedical engineering and the clinical translation of sensing technologies. Coverage is presented with technically curious, evidence-led, accessible and precise about engineering limitations, clinical validation and regulatory status.
Tessa is a MKNIRALO house editorial byline covering biomedical technology, wearable biosensors, biomarker detection, medical devices, molecular diagnostics and the translation of sensing technologies toward clinical use. The byline is maintained by MKNIRALO and is not a claim of an independently verified individual.
For publication-wide information about AI assistance, source standards and corrections, see the Transparency page and Editorial Policy. All authors and bylines
The designation covers patients aged 10 to under 18 and follows a short Phase 2 study. The company reports a sleep-time signal, but the full dataset remains under journal review and pediatric use is still investigational.
The four-year, up-to-$37.9 million project aims to build a body-heat-powered biosensor patch. But the agency's award record describes a narrower target, and the device still has to clear basic engineering and clinical tests.